Vibegron

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status
Vibegron 1190389-15-1 Dec.01, 2030 PV Completion

 

[Indication]

For the treatment of overactive bladder (OAB) with signs of urge urinary incontinence (UUI), urgency, and urinary frequency in adults.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us